Previous 10 | Next 10 |
Market resiliency due to seasonal tendencies and waning trade and war tensions have rekindled animal spirits, resulting in a shallow round of profit-taking prior to last week's march to new highs. Data by YCharts I wrote on Jan. 31 that "The ideal time to raise cash was during th...
Automating and securing the medication dispensing system throughout the hospital streamlines nursing workflow and helps improve patient care Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today ...
Omnicell, Inc. (OMCL) Q4 2019 Earnings Conference Call February 06, 2020, 04:30 AM ET Company Participants Peter Kuipers - CFO Randall Lipps - Founder, Chairman, President & CEO Conference Call Participants Lucas Baranowski - Craig-Hallum Capital Steve Halper - Cantor ...
Omnicell (NASDAQ: OMCL ): Q4 Non-GAAP EPS of $0.77 misses by $0.01 ; GAAP EPS of $0.51 beats by $0.01 . More news on: Omnicell, Inc., Earnings news and commentary, Tech stocks news, Read more ...
Record annual GAAP and non-GAAP revenues of $897.0 million Record 2019 GAAP net income per diluted share of $1.43 Record 2019 non-GAAP net income per diluted share of $2.81 Record ending product backlog of $588 million Omnicell, Inc. (NASDAQ:OMCL), a leading provider of...
Recent severe challenges in 503B supply creating need for novel, more reliable, and safer alternatives Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced significant clinical enh...
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, February 6, 2020, to discuss the Company’s Fourth Quarter 2019 financial results. About Omnicell ...
Smart medication management – using automation and data intelligence – is transforming patient care in hospitals across the U.S. Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, toda...
Central Pharmacy IV Compounding Service creates a safer, more accurate and cost-effective IV pharmacy Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Allegheny General Hosp...
The following slide deck was published by Omnicell, Inc. in conjunction with this Read more ...
News, Short Squeeze, Breakout and More Instantly...
Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will present at the BofA Securities 2024 Health Care Conference in Las Vegs, NV, on Wednesday, May 15, 2024 at 3:40 p.m. PT. Live and archived webcasts of the presentation will be available through the Om...
2024-05-03 08:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Results exceed prior first quarter guidance across all metrics Total GAAP revenues of $246 million Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a ...